Author Index: V

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Vadillo, M.
• THE ROLE OF PREDECISIONAL INFORMATION DISTORTION IN MISDIAGNOSIS
Valcarcel Salamanca, B.
• IS ONGOING ROTAVIRUS VACCINATION IN NORWAY COST-EFFECTIVE?
Valcarcel-Nazco, C.
• COMPARING ADOLESCENTS AND ADULT PREFERENCES TO EQ-5D-Y HEALTH STATES USING PROFILE CASE BEST-WORST SCALING
Van Calster, B.
• CLINICAL UTILITY OF PREDICTION MODELS FOR OVARIAN TUMOR DIAGNOSIS: A DECISION CURVE ANALYSIS
van de Poll-Franse, L. V.
• DEVELOPMENT OF HEALTH-RELATED QUALITY OF LIFE FOLLOWING PROSTATE CANCER DIAGNOSIS IS ASSOCIATED WITH OPTIMISM AND SELF-EFFICACY
van den Akker-van Marle, M. E.
• ORAL ABSTRACTS: EVALUATING SCREENING

• COST-EFFECTIVENESS OF PLANNED BIRTH IN A BIRTH CENTRE COMPARED WITH PLANNED BIRTH IN A HOSPITAL AND AT HOME IN WOMEN AT LOW-RISK OF COMPLICATIONS
van der Pal, K.
• COST-EFFECTIVENESS OF PLANNED BIRTH IN A BIRTH CENTRE COMPARED WITH PLANNED BIRTH IN A HOSPITAL AND AT HOME IN WOMEN AT LOW-RISK OF COMPLICATIONS
Van der Poel, H. G.
• THE EFFECT OF SALVAGE RADIOTHERAPY AND ITS TIMING ON THE HEALTH-RELATED QUALITY OF LIFE OF PROSTATE CANCER PATIENTS
van der Straten, M.
• THE USE OF BEST-WORST SCALING CASE 2 TO ESTIMATE INDIVIDUALIZED PREFERENCES FOR VALUE CLARIFICATION AND DECISION SUPPORT
Van der Weijden, T.
• A COMPARISON OF PATIENTS' AND HEALTHCARE PROFESSIONALS' PREFERENCES FOR THE CHARACTERISTICS OF DISEASE MODIFYING DRUGS IN DECISION MAKING ABOUT MULTIPLE SCLEROSIS TREATMENT
van Giessen, A.
• THE COST OF BEING WRONG: THE IMPACT OF PREDICTION UNCERTAINTY ON THE COST-EFFECTIVENESS OF RISK-STRATIFIED STRATEGIES

• RETHINKING METHODS TO IDENTIFY OPTIMAL TREATMENT AND DIAGNOSTIC THRESHOLDS: EVALUATING RISK-BASED OUTCOMES IN CORONARY HEART DISEASE
Van Huffel, S.
• CLINICAL UTILITY OF PREDICTION MODELS FOR OVARIAN TUMOR DIAGNOSIS: A DECISION CURVE ANALYSIS
Van Jaarsveld, W.
• THE MOST EFFICIENT CRITICAL VACCINATION COVERAGE AND ITS EQUIVALENCE WITH MAXIMIZING THE HERD EFFECT

• DOSE-OPTIMAL VACCINE ALLOCATION OVER MULTIPLE POPULATIONS
van Ravesteyn, N. T.
• PROBABILISTIC SENSITIVITY ANALYSIS OF COST-EFFECTIVENESS ANALYSIS OF THE BREAST CANCER SCREENING PROGRAMME IN THE BASQUE COUNTRY: A MULTI-COHORT DISCRETE-EVENT SIMULATION MODEL
van Stam, M. A.
• THE EFFECT OF SALVAGE RADIOTHERAPY AND ITS TIMING ON THE HEALTH-RELATED QUALITY OF LIFE OF PROSTATE CANCER PATIENTS
van Til, J. A.
• THE USE OF BEST-WORST SCALING CASE 2 TO ESTIMATE INDIVIDUALIZED PREFERENCES FOR VALUE CLARIFICATION AND DECISION SUPPORT
van Valkenhoef, G.
• STATIN BENEFIT-RISK PROFILES IN INDIVIDUALS AT INTERMEDIATE RISK FOR CARDIOVASCULAR DISEASE
van Vugt, J. P. P.
• THE USE OF BEST-WORST SCALING CASE 2 TO ESTIMATE INDIVIDUALIZED PREFERENCES FOR VALUE CLARIFICATION AND DECISION SUPPORT
Varalli-Claypool, B. M.
• DOES MEDICAL EDUCATION PROVIDE A SHARED UNDERSTANDING OF THE TREATMENT THRESHOLD PROBABILITY FOR SUSPECTED STREP THROAT?
Varesco, L.
• IF YOU WERE A BRCA MUTATION CARRIER WHAT WOULD YOU DO? FACTORS PREDICTING THE CHOICE OF PROPHYLACTIC OVARIECTOMY IN A SAMPLE OF ITALIAN WOMEN

• COMPARING YOUNG AND OLDER ITALIAN WOMEN ON PREFERENCES FOR BRCA TESTING AND RISK REDUCTION AND MANAGEMENT STRATEGIES
Vecino Ortiz, A.
• A RAPID INFLUENZA TEST IN HOSPITALS COULD AVOID UNNECESSARY PAEDIATRIC ISOLATION BED DAYS AND SAVE COSTS

• ESTIMATING THE CLINICAL IMPACT AND COSTS OF IMPLEMENTING A POINT OF CARE TEST FOR INFLUENZA A/B AND RESPIRATORY SYNCYTIAL VIRUS ON AN ACUTE PAEDIATRIC HOSPITAL INPATIENT WARD
Verbakel, J.
• CLINICAL UTILITY OF PREDICTION MODELS FOR OVARIAN TUMOR DIAGNOSIS: A DECISION CURVE ANALYSIS
Verschuren, M.
• FROM PREDICTED RISK TO PREDICTED BURDEN OF CARDIOVASCULAR DISEASE
von Laer, D.
• IMPROVING CERVICAL CANCER PRIMARY SCREENING AND DIAGNOSTIC FOLLOW-UP IN AUSTRIA – A DECISION-ANALYTIC BENEFIT-HARM ANALYSIS
Vukicevic, D.
• AN OVERVIEW OF DIFFERENT MAPPING TECHNIQUES TO DERIVE HEALTH STATE UTILITY VALUES IN MULTIPLE MYELOMA FOR DECISION-ANALYTIC MODELING

• COSTS OF FIRST-LINE TREATMENT FOR ELDERLY MULTIPLE MYELOMA PATIENTS WHO ARE NOT TRANSPLANT CANDIDATES IN THE SERBIAN HEALTH CARE SYSTEM

• META-ANALYSIS AND INDIRECT TREATMENT COMPARISON OF SAFETY PROFILES OF BORTEZOMIB- AND THALIDOMIDE-BASED REGIMENS FOR THE FIRST LINE TREATMENT OF ELDERLY TRANSPLANT-INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA

• TREATMENT STRATEGIES FOR MULTIPLE MYELOMA IN ELDERLY PATIENTS: A NETWORK META-ANALYSIS
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z